|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Affimed (NASDAQ: AFMD) through any online brokerage.
There are no as such competitors for Affimed.
The latest price target for Affimed (NASDAQ: AFMD) was reported by Credit Suisse on 2021-03-31. The analyst firm set a price target for 15.00 expecting AFMD to rise to within 12 months (a possible 52.91% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Affimed (NASDAQ: AFMD) is $9.81 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Affimed.
There is no upcoming split for Affimed.